FDA Clearance Tracker · DEN230011
OcuCool
Last checked: Nov 20, 2026Latest source record: Sep 30, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Sep 30, 2024
De Novo granted
Time to decision
592 days
Received Feb 16, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Not stated
The decision
- FDA number
- DEN230011
- Device name
- OcuCool
- Applicant
- Recensmedical, Inc.
- Applicant location
- Hwaseong-Si, KR
- Received
- Feb 16, 2023
- Decided
- Sep 30, 2024
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device type
- Product code (QZQ)
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN230011
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Recensmedical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TargetCool (RM-DT02W)510(k)
K253114 · Decided Oct 16, 2025 · 22 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
- TargetCool-e510(k)
K253348 · Decided Oct 15, 2025 · 15 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
- TargetCool510(k)
K230599 · Decided Jun 22, 2023 · 111 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.